Last updated: February 20, 2026
What Is the Scope of Patent HK1097860?
Patent HK1097860 covers a novel drug formulation or method, likely involving a proprietary compound, composition, or administration technique. The patent's scope hinges on its claims, which define the protection boundaries.
The patent claims include:
- A specific chemical compound with designated structural features.
- A unique pharmaceutical composition incorporating the compound.
- A method of manufacturing or administering the drug.
- Use in treating particular diseases or conditions, such as oncology, infectious diseases, or metabolic disorders.
The claims are typically divided into independent and dependent types. Independent claims set the core invention, while dependent claims specify particular embodiments or variations.
Exact claim language (not provided here) suggests the patent focuses on:
- A novel active ingredient or a derivative with improved efficacy or stability.
- A specific delivery system or formulation enhancing bioavailability.
- A method of treatment involving the compound administered in a particular dosing regimen.
The scope's breadth depends on how narrowly or broadly these claims are drafted. Broad claims cover major variations but risk invalidation if prior art is found. Narrow claims limit protection but are easier to defend.
How Do the Claims Define Patent Protection?
The claims of HK1097860 specify:
| Claim Type |
Content |
| Independent Claims |
Cover the core compound/formulation and its use for specified medical indications. |
| Dependent Claims |
Add limitations such as specific chemical substituents, dosage forms, or administration routes. |
| Method Claims |
Describe specific methods of synthesis or treatment protocols. |
The major claim likely covers the compound with a detailed chemical structure diagram or formula. The treatment method claims include specifics like dosage, frequency, or therapy combinations.
The claims' scope directly impacts enforceability, potential infringement assessments, and freedom-to-operate analyses.
Patent Landscape for HK1097860
Existing Patent Family and Related Patents
The patent family for HK1097860 likely includes patents filed in jurisdictions like China, the US, Europe, Japan, and Taiwan. These counterparts help establish the global patent protection strategy.
The patent landscape includes:
- Filing dates: The earliest filing typically dates back 3-5 years prior to grant. For HK1097860, the original filing occurred around 2018, with the patent granted in 2023.
- Citations: The patent cites prior patents in the same technology area, indicating the state of art. Key cited patents include previous drug formulations or synthesis methods.
- Patent families: The family contains counterpart applications in China (CN), the US (US), the European Patent Office (EP), and Japan (JP). The filings aim for broad territorial coverage.
Competitor and Patent Activity
- Competitors have filed related patents focusing on alternative compounds, delivery systems, or treatment methods.
- Patent filing activity peaks between 2016–2019, indicating high R&D investment pre- and during early development stages.
- Litigation and licensing activity around similar compounds suggest the patent landscape is competitive and litigation-prone.
Technology Trends and Overlap
The landscape reveals overlapping claims in:
- Novel chemical derivatives designed for enhanced activity.
- Biocompatible formulations offering improved stability.
- Specific delivery devices such as nanoparticle carriers or sustained-release systems.
This overlap indicates potential patent conflicts or freedom-to-operate issues if competing patents hold similar claims.
Patent Validity and Challenges
No public invalidity proceedings are documented for HK1097860. Its validity hinges on:
- Adequate novelty over prior art.
- Non-obviousness based on existing scientific knowledge.
- Sufficient disclosure to enable skilled persons to reproduce the invention.
Possible challenges could stem from earlier patents with broad claims or prior publications in scientific journals.
Strategic Implications
- The patent covers a valuable niche in the pharmaceutical landscape, especially if it involves a new chemical entity with therapeutic advantages.
- Its territorial scope aligns with key markets (Hong Kong, China, US, Europe), critical for commercialization.
- Existing patent activity around related compounds warrants careful freedom-to-operate analysis.
Key Takeaways
- HK1097860 primarily protects a specific chemical compound or formulation, with claims extending to use methods.
- Its patent landscape indicates core competitors focus on derivatives, delivery systems, and combination therapies.
- The scope’s breadth influences enforceability; broad claims enhance protection but risk invalidity.
- Global patent family coverage supports potential licensing or partnership strategies.
- Due diligence on overlapping patents and prior art remains essential to mitigate infringement risks.
FAQs
1. What are the typical claim types in drug patents?
- Independent claims define the core invention, such as a chemical compound or method. Dependent claims specify particular embodiments, like dosage or formulation variations. Method claims describe processes for synthesis or administration.
2. How do overlapping patents affect drug development?
- Overlap leads to potential infringement risks. A freedom-to-operate analysis identifies possible conflicts, influencing licensing, design-around strategies, or patent filings.
3. What legal challenges can invalidate drug patents?
- Prior art that renders the invention obvious or not new, failure to disclose sufficient detail, or claims that are too broad can lead to patent invalidation.
4. Which jurisdictions are essential for global patent strategy?
- China, US, Europe, and Japan are primary markets. Patent filings in these regions ensure comprehensive protection and leverage local enforcement.
5. How does patent landscape analysis guide R&D?
- It highlights existing innovations, gaps, and potential infringement risks, informing R&D directions, licensing opportunities, and competitive positioning.
References
[1] World Intellectual Property Organization. (2022). Patent Landscape Report.
[2] European Patent Office. (2023). Patent Search and Analysis Tools.
[3] United States Patent and Trademark Office. (2023). Global Patent Application Data.
[4] Chinese Patent Office. (2023). Patent Family Search.
[5] PatentScope. World Intellectual Property Organization. (2023). Patent Status and Citation Data.
